Literature DB >> 18676150

Synthesis and antimicrobial activity of dermaseptin S1 analogues.

Dianella Savoia1, Remo Guerrini, Erika Marzola, Severo Salvadori.   

Abstract

Dermaseptins are peptides found in the skin secretions of Phyllomedusinae frogs. These peptides exert lytic action on some microorganisms without substantial haemolysis. In an attempt to understand the antimicrobial activity of these peptides we designed several dermaseptin S1 (ALWKTMLKKLGTMALHAGKAALGAAADTISQGTQ) (DS1) analogues. All peptides were tested on the growth of prokaryotic (Gram-positive and Gram-negative bacteria) and eukaryotic (the yeast Candida albicans and the protozoon Leishmania major) organisms. Our data showed a dose-dependent killing effect by most DS1 derivatives. Maximal antibacterial activity was displayed by a 16-mer peptide that was more active than native DS1.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18676150     DOI: 10.1016/j.bmc.2008.07.032

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  9 in total

1.  Peptide-based Antifungal Therapies against Emerging Infections.

Authors:  A Matejuk; Q Leng; M D Begum; M C Woodle; P Scaria; S-T Chou; A J Mixson
Journal:  Drugs Future       Date:  2010-03       Impact factor: 0.148

Review 2.  Antimicrobial Peptides as a Promising Therapeutic Strategy for Neisseria Infections.

Authors:  Parvin Askari; Masoud Yousefi; Mohsen Foadoddini; Alireza Neshani; Mahdi Aganj; Nasim Lotfi; Aref Movaqar; Kiarash Ghazvini; Mohammad Hasan Namaei
Journal:  Curr Microbiol       Date:  2022-02-13       Impact factor: 2.188

3.  Guanidino groups greatly enhance the action of antimicrobial peptidomimetics against bacterial cytoplasmic membranes.

Authors:  Konstantin Andreev; Christopher Bianchi; Jonas S Laursen; Linda Citterio; Line Hein-Kristensen; Lone Gram; Ivan Kuzmenko; Christian A Olsen; David Gidalevitz
Journal:  Biochim Biophys Acta       Date:  2014-05-28

4.  Antitumor and angiostatic activities of the antimicrobial peptide dermaseptin B2.

Authors:  Hanneke van Zoggel; Gilles Carpentier; Célia Dos Santos; Yamina Hamma-Kourbali; José Courty; Mohamed Amiche; Jean Delbé
Journal:  PLoS One       Date:  2012-09-20       Impact factor: 3.240

5.  Current developments in the therapy of protozoan infections.

Authors:  Mario Zucca; Dianella Savoia
Journal:  Open Med Chem J       Date:  2011-03-09

Review 6.  Progress Report: Antimicrobial Drug Discovery in the Resistance Era.

Authors:  Pottathil Shinu; Abdulaziz K Al Mouslem; Anroop B Nair; Katharigatta N Venugopala; Mahesh Attimarad; Varsha A Singh; Sreeharsha Nagaraja; Ghallab Alotaibi; Pran Kishore Deb
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-28

Review 7.  Antimicrobial Peptides with Anti-Candida Activity.

Authors:  Aitzol Perez-Rodriguez; Elena Eraso; Guillermo Quindós; Estibaliz Mateo
Journal:  Int J Mol Sci       Date:  2022-08-17       Impact factor: 6.208

8.  Brevibacillin 2V, a Novel Antimicrobial Lipopeptide With an Exceptionally Low Hemolytic Activity.

Authors:  Xinghong Zhao; Xiaoqi Wang; Rhythm Shukla; Raj Kumar; Markus Weingarth; Eefjan Breukink; Oscar P Kuipers
Journal:  Front Microbiol       Date:  2021-06-17       Impact factor: 5.640

9.  The post-antibiotic era: promising developments in the therapy of infectious diseases.

Authors:  Mario Zucca; Dianella Savoia
Journal:  Int J Biomed Sci       Date:  2010-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.